Luton, Bedfordshire, United Kingdom, May 20, 2025 (GLOBE NEWSWIRE) — The global disposable arteriovenous (AV) cannula market is growing steadily, driven by rising chronic kidney disease rates and an aging population requiring dialysis and apheresis. In 2024 the market is estimated at about $2.5 billion and is forecast to reach roughly $4.1 billion by 2034, a 5.5% CAGR over the decade.
Get a Sample PDF Brochure: https://exactitudeconsultancy.com/reports/55125/global-disposable-arteriovenous-cannula-market#request-a-sample
North America leads with 40% share due to its extensive dialysis infrastructure and reimbursement coverage. Europe accounts for about 25%, while Asia-Pacific is the fastest-growing region (CAGR 7%) as China, India and others expand dialysis services. Latin America and Middle East/Africa currently contribute smaller shares but are increasing healthcare investments.
Market Segmentation
| Segment Category | Subsegment | Market Share (2024) | Estimated CAGR (2024–2034) |
| Product Type | Non-Tunneled Cannulas | 70% | 5–7% |
| Tunneled Cannulas | 30% | 4–6% | |
| Application | Hemodialysis | 55% | 5% |
| Apheresis | 25% | 6% | |
| End User | Hospitals | 60% | 5% |
| Dialysis Centers | 25% | 5% | |
| Home Healthcare | 15% | 10% | |
| Technology | Conventional Cannulas | 70% | 4% |
| Safety Cannulas | 30% | 10% | |
| Distribution | Offline (Direct/Dist.) | 85% | 4% |
| Online | 15% | 15% |
They are designed as strictly single-use devices; each cannula is disposed after one session to ensure sterility and prevent infection.
By Product Type
Non-tunneled cannulas (straight or dual-lumen needles used with AV fistulas/grafts) dominate (70% of market) because most dialysis is done via routine access. Tunneled cannulas (cuffed central catheters for long-term or emergency dialysis) account for the remaining 30%. Tunneled versions are more expensive and are used when patients lack mature fistulas or need immediate vascular access.
By Application
Hemodialysis is the largest use (55%). Growing chronic kidney disease and dialysis rates drive steady demand for cannulas. Apheresis (plasma exchange, cell separation) makes up 25% and is expanding as treatments (e.g. for autoimmune disease, plasma donation) increase. The rest of the market includes critical care and other uses (20%) where AV cannulas support extracorporeal therapies in ICU settings.
By End User
Hospitals purchase the largest volume (60%), reflecting high procedure volumes and bulk purchasing power. Many in-hospital dialysis units and ICU/OR departments require AV cannulas. Dialysis Centers (free-standing clinics) account for 25% with steady demand for outpatient dialysis. Home Healthcare (home dialysis and infusion) is about 15% but growing fastest (double-digit CAGR) as patient-friendly cannulas are adopted for home hemodialysis and at-home apheresis setups.
By Technology
Most cannulas are conventional single-use needles (70% share). Safety cannulas (30%) have built-in protections (retractable needles, shielding) to prevent needlestick injuries. Safety models command higher prices but are gaining adoption as hospitals and regulatory bodies prioritize worker safety. For example, many hospitals now require safety-engineered devices, fueling growth of safety cannula sales (projected 10%+ CAGR).
By Distribution Channel
The majority of cannulas (85%) are sold via offline channels: direct sales to healthcare facilities or through distributors and wholesalers. Online channels (B2B medical e-commerce platforms) account for 15% today but are growing rapidly (15%+ CAGR), accelerated by digitization of procurement. Increasingly, dialysis clinics and even some home-care providers purchase supplies online for convenience and wider selection.
Browse full Report – https://exactitudeconsultancy.com/reports/55125/global-disposable-arteriovenous-cannula-market
Market Drivers and Trends
- Rising Chronic Disease: Global increases in diabetes and hypertension are driving up chronic kidney disease (CKD) rates. Each new dialysis patient adds to the base demand for hemodialysis cannulas. As CKD prevalence continues to rise, this underpins solid long-term growth in the cannula market.
- Aging Population: Older adults have higher incidence of renal failure. Aging demographics in North America, Europe and parts of Asia mean more patients on dialysis and apheresis, boosting cannula usage.
- Infrastructure Expansion: Emerging regions (Asia-Pacific, Latin …